首页> 外文期刊>Cancers >Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging
【24h】

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging

机译:在吲哚菁绿色荧光成像下完全消除腹膜转移后,肝移植物中的活体供体肝脏再移植肝脏移植物

获取原文
           

摘要

The curability of chemotherapy-resistant hepatoblastoma (HB) largely depends on the achievement of radical surgical resection. Navigation techniques utilizing indocyanine green (ICG) are a powerful tool for detecting small metastatic lesions. We herein report a patient who underwent a second living donor liver transplantation (LDLTx) for multiple recurrent HBs in the liver graft following metastasectomy for peritoneal dissemination with ICG navigation. The patient initially presented with ruptured HB at 6 years of age and underwent 3 liver resections followed by the first LDLTx with multiple sessions of chemotherapy at 11 years of age. His alpha-fetoprotein (AFP) level increased above the normal limit, and metastases were noted in the transplanted liver and peritoneum four years after the first LDLTx. The patient underwent metastasectomy of the peritoneally disseminated HBs with ICG navigation followed by the second LDLTx for multiple metastases in the transplanted liver. The patient has been recurrence-free with a normal AFP for 30 months since the second LDLTx. To our knowledge, this report is the first successful case of re-LDLTx for recurrent HBs. Re-LDLTx for recurrent HB can be performed in highly select patients, and ICG navigation is a powerful surgical tool for achieving tumor clearance.
机译:化疗抗性肝细胞瘤(HB)的可固化性主要取决于实现自由基手术切除术。使用吲哚菁绿(ICG)的导航技术是一种用于检测小转移性病变的强大工具。我们在本文中报告了患者在肝移植物中进行多次反复化HBS的患者,该肝脏移植物在腹膜切除术后与ICG导航腹膜传播。患者最初在6岁时最初呈现HB的破裂,并进行3次肝切除术,然后在11岁时具有多次化疗的第一次LDLTX。他的α-胎蛋白(AFP)水平升高于正常限度以上,在第一个LDLTX后四年后,在移植的肝脏和腹膜中注意到转移。患者用ICG导航进行腹膜透明的HBS的转移切除术,然后在移植肝脏中的多个转移酶进行第二LDLTX。由于第二个LDLTX,患者在正常的AFP持续30个月内无复发。据我们所知,本报告是重复性HBS重新LDLTX的第一个成功案例。用于复发HB的RE-LDLTX可以在高度选择的患者中进行,ICG导航是实现肿瘤间隙的强大手术工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号